Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1990 Jun-Jul;81(6-7):701–706. doi: 10.1111/j.1349-7006.1990.tb02630.x

Possible Mechanisms of Resistance to cis‐Diamminedichloroplatinum (II) of Human Ovarian Cancer Cells

Yoshihiro Kikuchi 1, Ichiro Iwano 1, Munenori Miyauchi 1, Tsunekazu Kita 1, Michio Sugita 2, Yoshio Tenjin 2, Ichiro Nagata 1
PMCID: PMC6504050  PMID: 2119370

Abstract

The mechanism of cis‐diamminedichloroplatinum (II) (CDDP) resistance was examined by using a CDDP‐resistant (KFr) cell line established by continuous exposure of KF cells (derived from serous cystadenocarcinoma of the ovary) to escalating doses of CDDP. When KFr cells were incubated with 66.7 μM CDDP, the uptake of CDDP was significantly inhibited and the cellular content in the KFr cells was about a half of that in KF cells after incubation for 4 h. When the KF or KFr cells were incubated for 4 h with 100 μM CDDP, the release pattern of CDDP from KFr cells was similar to that from KF cells. In addition, the DNA histogram of both KF and KFr cells revealed that KF cells seemed to contain two clones of cell population and the KFr cells may have been selected by exposure to CDDP. At 3 h after intraperitoneal administration of 0.5 mg of CDDP per mouse to nude mice with KF or KFr tumor, the CDDP content in the KFr tumor was significantly lower than that in the KF tumor. In contrast, at 6 or 9 h after CDDP administration the CDDP content in the KFr tumor was significantly higher than that in the KF tumor. Furthermore, the KFr cells had cross‐resistance to various CDDP analogues including carboplatin. It was shown that cellular uptakes of two CDDP analogues into KFr cells were significantly lower than those into KF cells.

Keywords: Human ovarian cancer, CDDP resistance, CDDP analogue, Cross resistance

Full Text

The Full Text of this article is available as a PDF (320.2 KB).

REFERENCES

  • 1. ) Loehrer , P. J. and Einhorn , L. H. Cisplatin . Ann. Intern. Med. , 100 , 704 – 713 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Schabel , F. M. , Trader , M. W. , Laster , W. R. , Corbett , T. H. and Griswold , D. P. cis‐Dichlorodiammineplatinum (II): combination chemotherapy and cross‐resistance studies with tumors of mice . Cancer Treat. Rep. , 63 , 1459 – 1473 ( 1979. ). [PubMed] [Google Scholar]
  • 3. ) Eastman , A. and Bresnick , E. Studies on the resistance of a murine leukemia L1210 cell line to cis‐diamminedi‐chloroplatinum (II) . Biochem. Pharmacol. , 30 , 2721 – 2723 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Richon , V. M. , Schulte , N. and Eastman , A. Multiple mechanisms of resistance to cis‐diamminedichloro‐platinum (II) in murine leukemia L1210 cells . Cancer Res. , 47 , 2056 – 2061 ( 1987. ). [PubMed] [Google Scholar]
  • 5. ) Andrews , P. A. , Murphy , M. P. and Howell , S. B. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion . Cancer Res. , 45 , 6250 – 6253 ( 1985. ). [PubMed] [Google Scholar]
  • 6. ) Frei , E. , III , Cucchi , C. A. , Rosowsky , A. , Tantaravaki , R. , Bernal , S. , Ervin , T. J. , Ruprecht , R. M. and Haseltine , W. A. Alkylating agent resistance: in vitro studies with human cell lines . Proc. Natl. Acad. Sci. USA , 82 , 2158 – 2162 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. ) Zwelling , L. A. , Michaels , S. , Schwartz , H. , Dobson , P. P. and Kohn , K. W. DNA cross‐linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis‐diamminedichloroplatinum (II) and l‐phenylalanine mustard . Cancer Res. , 41 , 640 – 649 ( 1981. ). [PubMed] [Google Scholar]
  • 8. ) Strandberg , M. C. Studies on the resistance of a murine leukemia L1210 cell line to cis‐diamminedichloroplatinum (II) . Proc. Am. Assoc. Cancer Res. , 22 , 202 ( 1981. ). [Google Scholar]
  • 9. ) Strandberg , M. C. , Bresnick , E. and Eastman , A. The significance of DNA cross‐linking to cis‐diamminedichlo‐roplatinum (II)‐induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells . Chem.-Biol. Interact. , 39 , 169 – 180 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Teicher , B. A. , Holden , S. A. , Kelly , M. J. , Shea , T. C. , Cucchi , C. A. , Rosowsky , A. , Henner , W. D. and Frei , E. , III . Characterization of a human squamous cell line resistant to cis‐diamminedichloroplatinum (II) . Cancer Res. , 47 , 388 – 393 ( 1987. ). [PubMed] [Google Scholar]
  • 11. ) Eichholtz‐Wirth , H. and Hietel , B. The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro . Br. J. Cancer , 54 , 239 – 243 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Kraker , A. J. and Moore , C. W. Accumulation of cis‐diamminedichloroplatinum (II) and platinum analogues by platinum‐resistant murine leukemia cells in vitro . Cancer Res. , 48 , 9 – 13 ( 1988. ). [PubMed] [Google Scholar]
  • 13. ) Andrews , P. A. , Velury , S. , Mann , S. C. and Howell , S. B. cis‐Diamminedichloroplatinum (II)‐resistant sublines derived from two human ovarian tumor cell lines . Cancer Res. , 48 , 68 – 73 ( 1988. ). [PubMed] [Google Scholar]
  • 14. ) Kuppen , P. J. K. , Schuitemaker , H. , van't Veer , L. J. , de Brujin , E. A. , van Oosterom , A. T. and Schrier , P. I. cis‐Diamminedichloroplatinum (II)‐resistant sublines derived from two human ovarian tumor cell lines . Cancer Res. , 48 , 3355 – 3359 ( 1988. ). [PubMed] [Google Scholar]
  • 15. ) Kikuchi , Y. , Iwano , I. , Miyauchi , M. , Kita , T. , Oomori , K. , Kizawa , I. , Sugita , M. and Tenjin , Y. The mechanism of acquired resistance to cisplatin by a human ovarian cancer cell line . Jpn. J. Cancer Res. , 79 , 632 – 635 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Kikuchi , Y. , Miyauchi , M. , Kizawa , I. , Oomori , K. and Kato , K. Establishment of a cisplatin‐resistant human ovarian cancer cell line . J. Natl. Cancer Inst. , 77 , 1181 – 1185 ( 1986. ). [PubMed] [Google Scholar]
  • 17. ) Kikuchi , Y. , Iwano , I. and Kato , K. Effect of calmodulin antagonists on human ovarian cancer cell proliferation in vitro . Biochem. Biophys. Res. Commun. , 123 , 385 – 392 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Krishan , A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining . J. Cell. Biol. , 66 , 188 – 193 ( 1975. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Yen , A. and Fairchild , D. G. T cell control of B cell proliferation uncoupled from differentiation . Cell. Immunol. , 74 , 269 – 276 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Litterst , C. L. , Gram , T. E. , Dedrick , R. L. , Leroy , A. and Guarino , A. M. Distribution and disposition of platinum following intravenous administration of cis‐diamminedi‐chloroplatinum (II) (NSC 119875) to dogs . Cancer Res. , 36 , 2340 – 2344 ( 1976. ). [PubMed] [Google Scholar]
  • 21. ) Byfield , J. E. and Calabro‐Jones , P. M. Carrier‐dependent and carrier‐independent transport of anti‐cancer alkylating agents . Nature , 294 , 281 – 283 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Scanlon , K. J. , Salfirstein , R. L. , Thies , H. , Gross , R. B. , Waxman , S. and Guttenplan , J. B. Inhibition of amino acid transport by cisplatin and its derivatives in L1210 murine leukemia cells . Cancer Res. , 43 , 4211 – 4215 ( 1983. ). [PubMed] [Google Scholar]
  • 23. ) Gross , R. B. , Waxman , S. and Scanlon , K. J. Amino‐acid membrane transport properties of L1210 cells resistant to cisplatin . Chemotherapia , 5 , 37 – 42 ( 1986. ). [PubMed] [Google Scholar]
  • 24. ) Fraval , H. N. A. and Roberts , J. J. G1 phase Chinese hamster V79–379A cells are inherently more sensitive to platinum bound to their DNA than mid S phase or asynchronously treated cells . Biochem. Pharmacol. , 28 , 1575 – 1580 ( 1979. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES